Literature DB >> 31027928

Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspective.

Nora Dellepiane1, Sonia Pagliusi2.   

Abstract

Vaccines play an essential role in preventing infectious diseases. Their registration in importing countries is often cumbersome and unpredictably lengthy, leading to delays in vaccine access for populations that need them most. This report builds on a previous publication identifying challenges for registration of vaccines in emerging countries. As a matter of social responsibility, it was judged necessary to address the challenges and offer a set of solutions for open dialogue. Based on regular exchange of information and experiences, a group of regulatory experts from the vaccine industry developed three sets of proposals for consideration by vaccine stakeholders, with a view to improving the situation, by fostering regulatory convergence, with viable options for streamlining registration procedures through reliance on other experienced regulators or international agencies. Further, it offers options for alignment of structure and contents of Common Technical Document modules and presents a harmonized template application form that could potentially be used by all countries.
Copyright © 2019.

Entities:  

Keywords:  CTD; Inspection; Procurement; Registration; Reliance; Testing

Year:  2019        PMID: 31027928     DOI: 10.1016/j.vaccine.2019.03.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.

Authors:  Benoit Hayman; Alex Bowles; Beth Evans; Elizabeth Eyermann; Lyudmila Nepomnyashchiy; Sonia Pagliusi
Journal:  Vaccine       Date:  2021-01-22       Impact factor: 3.641

2.  What can vaccines learn from aviation?

Authors:  Thierry Gastineau
Journal:  Vaccine       Date:  2020-06-18       Impact factor: 3.641

3.  Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report.

Authors:  Laura Viviani; Kirsty Reid; Thierry Gastineau; Catherine Milne; Dean Smith; Robin Levis; Dianliang Lei; Mark van Ooij; Philippe Alexandre Gilbert; Joris Vandeputte; Jianxun Xie; Leena Madhuri; Shahjahan Shaid; Vaughn Kubiak; Rajinder Suri; Takuo Mizukami; Yoshihisa Shirasaki; Xiantang Li; Ying-Ying Zhou; Alla Trapkova; Sunil Goel; Jai Prakash; Amrullah Aninditio Subagio; Eniek Suwarni; Kyung Jin Jung; Gautam Sanyal; Pradip Das; Emmanuelle Coppens; David Wright; Zhechu Peng; Helle Northeved; Carmen Jungbäck; Tatiana Kirpitchenok; Lorenzo Del Pace; Borami Seo; Brinda Poojary; Antoniana Ottoni
Journal:  Biologicals       Date:  2022-07-12       Impact factor: 1.760

4.  Influenza Illness and Partial Vaccination in the First Two Years of Life.

Authors:  Abram L Wagner; Lionel Gresh; Nery Sanchez; Guillermina Kuan; John Kubale; Roger Lopez; Sergio Ojeda; Eduardo Azziz-Baumgartner; Angel Balmaseda; Aubree Gordon
Journal:  Vaccines (Basel)       Date:  2021-06-20

5.  Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.

Authors:  Sonia Pagliusi; Maureen Dennehy; Akira Homma
Journal:  Vaccine       Date:  2020-06-10       Impact factor: 3.641

6.  Emerging vaccine manufacturers are innovating for the next decade.

Authors:  Benoit Hayman; Sonia Pagliusi
Journal:  Vaccine X       Date:  2020-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.